LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply
AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.
—
Filed today
—
Companies tracked
NSE & BSE
Listed on
👋Welcome back, there — you're tracking 0 companies
🔔Sign in free to track companies and get alerts the moment they file
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors
Latest Filings —
📋 Filing Types Available on ForgeUp Filings
Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Veerhealth Care just secured another large order from a major USA online retailer for Rs. 1.43 Crores in personal care products.
🤖 AI Summary
Repeat order from USA e-commerce platform valued at Rs. 1.43 Crores for personal care products
Fourth major order win in 27 days — signals sustained demand across domestic and export markets
Follows Rs. 6.16 Crore and Rs. 6.15 Crore domestic FMCG orders, plus earlier Rs. 1.50 Crore USA export deal
Filed as company update via press release to BSE on 30 April 2026
🔢 Key Numbers — exact figures from BSE filing, not rounded
Repeat order value
Rs. 1.43 Crores
Orders in 27 days
4 major orders totalling Rs. 12.31 Crores
Client geography
USA e-commerce platform (repeat customer)
🏢 How This Affects the Company
📈
Business Impact
Fourth order in 27 days validates sales execution and market acceptance. Repeat order from same USA e-commerce client signals customer retention and confidence in product quality and delivery.
💰
Financial Impact
Rs. 1.43 Crores adds to revenue pipeline alongside Rs. 12.31 Crores in documented orders (Rs. 6.16 Cr + Rs. 6.15 Cr + Rs. 1.50 Cr + Rs. 1.43 Cr). Contributes to near-term cash inflows subject to agreed payment terms.
⚙️
Operational Impact
Fourth order in rapid succession creates sustained manufacturing and fulfillment workload. Vapi facility (224 Plot, Vibrant Business Park) execution capacity is being stress-tested across multiple client timelines.
⚠️
Risk Impact
Rapid order concentration in short timeframe creates execution risk. Repeat customer dependency on USA e-commerce segment increases geopolitical and supply chain exposure.
👥 What This Means For Shareholders
✅
Action Required
No action required. Monitor Q4 FY26 results for revenue recognition and execution status of Rs. 12.31 Crores order backlog.
👤
Who Is Affected
All equity shareholders benefit from revenue pipeline expansion. Execution risk affects valuation of all shareholding classes equally.
🔍
Management Signal
Rapid order wins signal aggressive sales execution and validated product-market fit. Repeat orders indicate quality assurance and customer satisfaction, supporting management credibility on revenue target achievement.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q4 FY26 revenue results — verify Rs. 12.31 Crores order backlog revenue recognition status
Management guidance on Vapi facility capacity utilization and delivery timelines for four concurrent orders
Next BSE disclosure — confirm order execution completion and payment settlement by June 2026
MEDIUM RISKFour orders in 27 days create execution concentration. Vapi facility capacity stress and USA e-commerce client dependency require monitoring. Repeat order values trending lower (Rs. 1.50 Cr to Rs. 1.43 Cr).
💡 Investor Takeaway
Veerhealth Care secured Rs. 1.43 Crores repeat order from USA e-commerce platform — fourth major award in 27 days totalling Rs. 12.31 Crores documented. Repeat customer confirms retention and quality acceptance. Execution risk and capacity scaling are critical watch points.
⚖️ Strengths & Concerns
✅ Positives
Fourth major order in 27 days demonstrates consistent sales execution and validated market demand across segments.
Repeat order from same USA e-commerce platform confirms customer satisfaction and product quality acceptance.
⚠️ Concerns
All recent orders clustered in 27-day window creates execution and capacity concentration risk at Vapi facility.
Repeat order value Rs. 1.43 Crores is 23% lower than prior USA order, suggesting order value volatility or customer tier differentiation.
📅 Company Track Record
Veerhealth Care filed four order-win disclosures in 27 days (11-30 April 2026): Rs. 1.50 Cr USA export (11 April), Rs. 6.15 Cr domestic FMCG (17 April), Rs. 6.16 Cr domestic FMCG (20 April), Rs. 1.43 Cr USA repeat (29-30 April). Demonstrates sustained sales momentum in FY26, with domestic FMCG orders representing 77% of documented pipeline value.
Based on publicly available historical data. For context only.
All BSE filings we have analysed for Veerhealth Care Ltd.
You've read one filing
There are 32,000 more, and one of them is about a company you own
Follow a company and we'll email you the moment it files
again — explained, not just forwarded. Free.
Follow companies and get filings by email
Save any filing to read later
Two full AI analyses every month, free
No card needed. Sign in with Google in two taps.
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔖
Save filings you care about
Sign in free to save any filing and get notified when the same company files again.
🔖
Save This Filing
Sign in with Google to save this filing and get notified when this company files again. Free, takes 5 seconds.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.